In one of the largest real-world studies to date examining obesity treatment use and long-term weight changes after GLP-1 discontinuation, researchers at Cleveland Clinic found that many patients successfully stabilized their weight after one year through alternative treatments and therapeutic lifestyle interventions
Dysregulated metabolism and behaviors by disrupting gut microbiota in prenatal and neonatal mice
Protein Cell 11 , 680687 (2020)
In its main 56-week clinical trial, patients on the highest dose lost an average of 8 percent of their starting body weight
Ultimately, it was determined that a water content range of 512% should be used to produce suppositories with excellent physical stability
While Novo Nordisk and Lilly seem best positioned now, emerging agents, oral options, dual/triple agonist molecules may capture niches or even displace certain uses of the first wave of GLP-1s